Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases. [electronic resource]
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Jul 2006
- e19-22 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1537-6591
10.1086/505222 doi
Aged Antibodies, Monoclonal--adverse effects Antirheumatic Agents--adverse effects Arthritis--drug therapy Female Glucocorticoids--therapeutic use Humans Infliximab Leprostatic Agents--therapeutic use Leprosy, Borderline--chemically induced Male Middle Aged Tumor Necrosis Factor-alpha--antagonists & inhibitors